Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein
- 29 May 1995
- journal article
- Published by Wiley in FEBS Letters
- Vol. 365 (2-3), 159-163
- https://doi.org/10.1016/0014-5793(95)00466-m
Abstract
Ecotin, a serine protease inhibitor found in the periplasm of Escherichia coli, has been characterized as a potent reversible tight-binding inhibitor of the human contact activation proteases factor XIIa (FXIIa) and plasma kallikrein, having Ki values of 89 pM and 163 pM, respectively. Ecotin also inhibited human leukocyte elastase (HLE) with high affinity (Ki = 55 pM). The association rate constants kon for FXIIa and kallikrein were 5.3 × 105 M−1·s−1 and 2.9 × 105 M−1·s−1, respectively. The dissociation rate constant koff for kallikrein, measured in the presence of HLE to prevent reassociation, was 6.3 × 10−5 s−1; the koff for ecotin with FXIIa was 4.7 × 10−5 s−1. Both FXIIa and kallikrein cleaved ecotin slowly at pH 5.0, identifying Met-84 as the P1 residue. The potent anticoagulant effect by ecotin is explained by the coincident inhibition of FXIIa, kallikrein, and FXa and suggests that it may be useful in the study of inflammatory or thrombotic disorders such as sepsis or cardiopulmonary bypassKeywords
This publication has 26 references indexed in Scilit:
- Alteration of the specificity of ecotin, an E. coli serine proteinase inhibitor, by site directed mutagenesisFEBS Letters, 1994
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.Journal of Clinical Investigation, 1993
- Natural protein proteinase inhibitors and their interaction with proteinasesEuropean Journal of Biochemistry, 1992
- The Role of Plasma Proteases in Septic ShockNew England Journal of Medicine, 1989
- Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.Journal of Clinical Investigation, 1986
- Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.Journal of Clinical Investigation, 1986
- In vivo significance of kinetic constants of protein proteinase inhibitorsBiochemical Medicine, 1984
- Protein Inhibitors of ProteinasesAnnual Review of Biochemistry, 1980
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967